rgbp Archives

Regen BioPharma Inc (OTCMKTS: RGBP) Breaking Out as Biotech Files Patent on Dendritic Cell Technologies to Augment Efficacy of Survivin mRNA Cancer Immunotherapeutic Vaccine

Regen BioPharma Inc (OTCMKTS: RGBP) is making a powerful reversal rocketing back into penny land on Friday up 46% on $1.6 million in dollar volume. RGBP...

BioPharma3 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Under Accumulation as Biotech Sleeper Makes Major Reversal Northbound (A look at Intellectual Property / mRNA Vaccine)

Regen BioPharma Inc (OTCMKTS: RGBP) is on the rise in recent trading since reversing off $0.0034 lows last week. RGBP has seen significant decline in recent...

Featured3 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Major Reversal Brewing as Biotech Looks to Commercialize its Modified mRNA anti-cancer Vaccine & Accelerate Clinical Development of its NR2F6 Therapies

Regen BioPharma Inc (OTCMKTS: RGBP) has been steadily dropping since topping out at $0.0819 in September of last year. Now it looks like its oversold and...

BioPharma4 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Northbound as Biotech Grows Valuable Patent Portfolio & Grants 2 Licenses to Oncology Pharma for $1.9 Million

Regen BioPharma Inc (OTCMKTS: RGBP) has been moving steadily northbound in recent trading as speculators move back into the stock and bid it higher. On Friday...

BioPharma4 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Heats Up as Biotech Up Lists & Signs LOI to Acquire Canary Oncoceutics, Inc

Regen BioPharma Inc (OTCMKTS: RGBP) is getting noticed by some heavy hitters after the Company reported earlier this week in its first press release since going...

Emerging Markets4 years ago

Regen BioPharma Inc (OTCMKTS: RGBP) Mega Runner as Biotech Moves Towards “Pink Current” & Cancer Vaccine Patent Approved

Regen BioPharma Inc (OTCMKTS: RGBP) is making a powerful run up the charts after the Company’s Cancer Vaccine Patent was approved August 17th 2021 Exclusively for...

Micro Cap Daily

Regen BioPharma Inc (OTCMKTS: RGBP) Breaking Out as Biotech Files Patent on Dendritic Cell Technologies to Augment Efficacy of Survivin mRNA Cancer Immunotherapeutic Vaccine

Regen BioPharma Inc (OTCMKTS: RGBP) Under Accumulation as Biotech Sleeper Makes Major Reversal Northbound (A look at Intellectual Property / mRNA Vaccine)

Regen BioPharma Inc (OTCMKTS: RGBP) Major Reversal Brewing as Biotech Looks to Commercialize its Modified mRNA anti-cancer Vaccine & Accelerate Clinical Development of its NR2F6 Therapies

Regen BioPharma Inc (OTCMKTS: RGBP) Northbound as Biotech Grows Valuable Patent Portfolio & Grants 2 Licenses to Oncology Pharma for $1.9 Million

Regen BioPharma Inc (OTCMKTS: RGBP) Heats Up as Biotech Up Lists & Signs LOI to Acquire Canary Oncoceutics, Inc

Regen BioPharma Inc (OTCMKTS: RGBP) Mega Runner as Biotech Moves Towards “Pink Current” & Cancer Vaccine Patent Approved

Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis

Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments

Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024

Sonoma Pharmaceuticals (NASDAQ: SNOA): Potential Surge to Speculations – What Lies Ahead?

1847 Holdings (NYSE: EFSH) Soars: Insights, Acquisitions, and What Lies Ahead

Spooz, Inc. (OTC: SPZI): Decoding the 7800% Surge and Unseen Potential

Rainmaker Worldwide (OTC: RAKR): Exploring Recent Fluctuations & Strategic Acquisition

Nitches’ (OTC: NICH) Expansion Roadmap: Latest Developments & What to Expect in 2024

Buyer Group International’s (OTC: BYRG) Journey: Unearthing Potential with Strategic Exploration

Understanding ECGI Holdings’ (OTC: ECGI) Surge: Exploring the Recent Developments and What Lies Ahead

Bitfarms (NASDAQ: BITF) in Focus: Exploring the Meteoric 110% Surge and Macro Influences

The Crypto Company (OTC: CRCW) Skyrockets 1000%: Understanding the Surge and Potential Impact

BlockQuarry Corp’s (OTC: BLQC) Exponential Growth: Understanding the Phenomenon

Brainstorm Cell Therapeutics’ (NASDAQ: BCLI) Post-Setback Resurgence: Unpacking FDA Impact & Market Expectations

iSun, Inc (NASDAQ: ISUN) on the Rise: Recent Market Growth & Remarkable Momentum

Uncovering CS Diagnostics (OTC: FZRO): Behind the 117% Gain & Market Opportunity

Apollomics (NASDAQ: APLM) Market Momentum: Pipeline Potential, Market Trends, and Retail Insights

Processa Pharmaceuticals (NASDAQ: PCSA): Revolutionizing Cancer Treatment through Next-Generation Chemotherapies

Boardroom Battles and AI Fears: The OpenAI Story Unfolded

AB International Group (OTC: ABQQ) Beyond the Numbers: Strategic Evolution in the Entertainment Industry

Star Alliance International (OTC:STAL): Unpacking the 340% Gain & Future Prospects

Music Licensing Inc. (OTC: SONG): Unraveling the 1250% Surge and Current Valuation

Novo Integrated Sciences (NASDAQ: NVOS): From 350% Peaks to Controversial Shifts and Potential Catalysts

TG Therapeutics (NASDAQ: TGTX): Bullish Analysts & Breakthrough Treatment in Relapsing MS

BlueFire Technology Corp. (OTC: BLFR): Bold Ambitions & Path to NASDAQ Uplisting

A2Z Smart Technologies (NASDAQ: AZ): Unveiling the Future of Shopping & Global Expansion

3DX Industries (OTC: DDDX): Revolutionizing Manufacturing & Government Contracts

FingerMotion (NASDAQ: FNGR): Latest Developments and Ongoing Investigations

“Nouveau Monde Graphite (NYSE: NMG): Leveraging China’s Restrictions on Graphite Exports

SAB Biotherapeutics (NASDAQ: SABS): Makes Strides in Type 1 Diabetes

Galera Therapeutics (NASDAQ: GRTX) in Focus: Exploring Catalysts Ahead of FDA’s Verdict

Nkarta Inc. (NASDAQ: NKTX): Breakthrough in NK Cell Therapy for Lupus Nephritis

Astra Energy (OTCQB: ASRE): Pioneering Renewable Power and Market Momentum

Meta Materials’ (NASDAQ:MMAT) Journey: Legal Hurdles, Innovation and Future Potential

Tempest Therapeutics (NASDAQ: TPST) Soars 2,879%: From Downturn to Breakthrough in Clinical Trials

Splash Beverage’s (NYSE: SBEV) Meteoric Surge: Can It Rival Beverage Industry Giants?

Clean Vision Corporation (OTC: CLNV): Understanding the 180% Surge and Key Insights

Orchard Therapeutics’ (NASDAQ: ORTX) Shares Skyrocket: How To Predict Biotech M&A

Vivos Therapeutics (NASDAQ: VVOS) Strategic Moves: A Step Forward in Sleep Disorder Solutions

IceCure Medical’s (NASDAQ: ICCM) ProSense: A 96.8% Success Rate Revolutionizing Breast Cancer Treatment

T2 Biosystems (NASDAQ: TTOO) Breaks Ground: FDA Clearance, Market Trends, and Healthcare Impact

Organogenesis (NASDAQ: ORGO): Latest Developments and Future Growth Prospects

Femasys’ (NASDAQ: FEMY) FemaSeed Receives FDA Nod: A Game-Changer for Infertility Treatment

Vaccitech (NASDAQ: VACC) Gains Unprecedented Support—What’s Behind It?

MSP Recovery (NASDAQ: LIFW) in the Spotlight: Legal Battles, Luxe Living, and Stock Surge

Solowin Holdings (NASDAQ: SWIN) 95% Stock Rally: Analyzing the Market Hype and IPO Impact”

Advancing Medical Frontiers: Elutia Inc.’s(NASDAQ: ELUT) Strategic Vision in a $600 Million Market

FingerMotion, Inc. (NASDAQ: FNGR): A Closer Look at its 500% Surge

Navigating the Green Wave: US Cannabis ETF (NYSE: MSOS) A Closer Look at Cannabis Stock Resurgence

First Wave BioPharma’s (NASDAQ: FWBI) Exclusive License: Repurposing Capeserod for GIT Disorder Solutions

Entertainment

Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis

Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments

Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024

Sonoma Pharmaceuticals (NASDAQ: SNOA): Potential Surge to Speculations – What Lies Ahead?

1847 Holdings (NYSE: EFSH) Soars: Insights, Acquisitions, and What Lies Ahead

Spooz, Inc. (OTC: SPZI): Decoding the 7800% Surge and Unseen Potential

Rainmaker Worldwide (OTC: RAKR): Exploring Recent Fluctuations & Strategic Acquisition

Nitches’ (OTC: NICH) Expansion Roadmap: Latest Developments & What to Expect in 2024

Buyer Group International’s (OTC: BYRG) Journey: Unearthing Potential with Strategic Exploration

Clean Vision Corp (OTC: CLNV): Overcoming the Plastic Waste Crisis

Meta Materials (NASDAQ: MMAT): More Due Diligence and Exploring Latest Developments

Integrated Cannabis Solutions’ (OTC: IGPK) 633% Surge: Exploring Catalysts, Company Overview, and Growth Potential in 2024

Meta Materials Inc (OTCMKTS: MMTLP) Enormous Short Position in Trouble as Next Bridge Hydrocarbons Set to Stop Trading (George Palikaras & John Brda on Corporate Action)

Medium (KOK PLAY) The Parabolic Rise of Metal Arts (OTCMKTS: MTRT)

Healthier Choices Management Corp. (OTCMKTS: HCMC) Powerful Comeback Brewing as PMI Patent Infringement Lawsuit Moves Forward

Recent Posts

Recent Comments